 |
|
U of MN uses robotic surgery techniques in cardiac cell therapy research
August 01, 2006Researchers at the University of Minnesota were successful in using robotic surgery to deliver stem cell treatment to damaged heart tissue in pigs.
Using minimally invasive robotic surgery equipment, researchers injected the stem cells into the damaged hearts. The cells were "labeled" with iron particles so that researchers would be able to see if they engrafted in the pig hearts.
The cells were successfully transplanted in six of seven cases. Subsequent MRI studies showed that the cells took hold in the heart and function improved.
The team used a combination of skeletal myoblasts, or cells that give rise to muscle, and bone-marrow derived cells. Both cell types have been shown to improve the development of new blood vessels and to improve function of injured heart muscle. Both are in human clinical trials as well.
The research is published in the current issue of the Journal of Thoracic and Cardiovascular Surgery.
Once more animal studies are completed, the technique could be applied in human clinical trials.
"In people with heart failure, open surgery can be risky; finding a minimally invasive technique to deliver cell therapy to the damaged cardiac tissue would reduce the risk to patients," said Doris A. Taylor, Ph.D., professor of Physiology, holder of the Medtronic Bakken Chair in Cardiovascular Repair, and co-leader of the study.
The minimally invasive approach would offer several benefits for people in heart failure, Taylor said. It is less dangerous to the patient. It can be done while the heart is still beating, and requires less time under anesthesia. It also offers surgeons a magnified view of the heart and allows them to target the cell infusion more precisely.
Harald Ott, M.D., co-leader of this study, now a surgery resident at Massachusetts General Hospital in Boston, pointed out, "Currently these types of cell therapies, in which stem cells are injected into damaged hearts, are only available to people who are enrolled in clinical research trials."
Skeletal and bone marrow cells that are injected into damaged heart tissue have been shown to improve function in the left ventricle, the chamber of the heart that pumps blood into the aorta, the main artery through which oxygen-rich blood flows from the heart to the body.
Taylor said more research needs to be done to determine which types of cells are most beneficial to infuse into damaged hearts, as well as if the minimally invasive technique can deliver similar results as traditional open surgery. "But that is what keeps us busy," she added," finding the best treatment for patients with heart disease."
University of Minnesota
The team used a combination of skeletal myoblasts, or cells that give rise to muscle, and bone-marrow derived cells. Both cell types have been shown to improve the development of new blood vessels and to improve function of injured heart muscle. Both are in human clinical trials as well.
The research is published in the current issue of the Journal of Thoracic and Cardiovascular Surgery.
Once more animal studies are completed, the technique could be applied in human clinical trials.
"In people with heart failure, open surgery can be risky; finding a minimally invasive technique to deliver cell therapy to the damaged cardiac tissue would reduce the risk to patients," said Doris A. Taylor, Ph.D., professor of Physiology, holder of the Medtronic Bakken Chair in Cardiovascular Repair, and co-leader of the study.
The minimally invasive approach would offer several benefits for people in heart failure, Taylor said. It is less dangerous to the patient. It can be done while the heart is still beating, and requires less time under anesthesia. It also offers surgeons a magnified view of the heart and allows them to target the cell infusion more precisely.
Harald Ott, M.D., co-leader of this study, now a surgery resident at Massachusetts General Hospital in Boston, pointed out, "Currently these types of cell therapies, in which stem cells are injected into damaged hearts, are only available to people who are enrolled in clinical research trials."
Skeletal and bone marrow cells that are injected into damaged heart tissue have been shown to improve function in the left ventricle, the chamber of the heart that pumps blood into the aorta, the main artery through which oxygen-rich blood flows from the heart to the body.
Taylor said more research needs to be done to determine which types of cells are most beneficial to infuse into damaged hearts, as well as if the minimally invasive technique can deliver similar results as traditional open surgery. "But that is what keeps us busy," she added," finding the best treatment for patients with heart disease."
University of Minnesota
Cardiac cell transplant studies show promise in cardiac tissue repair
Two studies published in the current issue of CELL TRANSPLANTATION (17:6) examine the efficacy of transplanting bone marrow cells (BMCs) for the repair of heart tissue.
Menstrual blood -- a valuable source of multipotential stem cells?
Researchers seeking new and more abundant sources of stem cells for use in regenerative medicine have identified a potentially unlimited, noncontroversial, easily collectable, and inexpensive source - menstrual blood.
More Cardiac Cell Therapy Current Events and Cardiac Cell Therapy News Articles
 |
An Essential Guide to Cardiac Cell Therapy by Emerson Perin (Author), James T. Willerson (Author) Sparked by a new understanding that the development of tissues is not restricted to the embryonic phase of development and thus that regeneration of tissues can occur in adults, the emerging field of stem cell therapy has grown exponentially in the last several years. Crucially, the research and findings associated with stem cell research overlap into many other areas, such as basic cell biology, molecular biology and hematology, and the proliferation of clinical studies involving stem cell research is gradually crossing over into the practice of medicine as many patients may become candidates for such novel treatments. As a response to this, Guide to Cardiac Cell Therapy is a comprehensive but understandable resource that makes this exciting field accessible to clinical practitioners.... |
 |
Heart Failure Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough oxygenated blood to meet the needs of the body?s other organs. The heart keeps pumping, but not as efficiently as a healthy heart. Usually, the loss in the heart?s pumping action is a symptom of an underlying heart problem. Heart failure affects nearly 5 million US adults. It is on the rise with an estimated 400,000 to 700,000 new cases each year. This talk will focus on the causes, symptoms, diagnosis and treatments available for heart failure, including current research findings from Stanford. |
 |
Handbook Of Cardiac Stem Cell Therapy by Ioannis Dimarakis (Author) This book is an impressive compilation of contributions on the hot topic of cardiac stem cell therapy from leading groups all over the world. In the assembly of chapters, a structured approach is adopted; starting from the clinician's perspective, all developments in both the experimental and clinical research areas are covered. This journey will take the reader from the bench-top to the bedside, with all chapters written by leading authorities in their respective fields, including data still in press with medical journals. So, beyond being excellent as an overall update for scientists in the field of cardiac stem cell therapy, this book will likely prove an indispensable tool for every budding scientist considering a research project within this field. Contents: The... |
 |
Cardiac Cell and Gene Transfer (Methods in Molecular Biology) by Joseph M. Metzger (Editor) Univ. of Michigan, Ann Arbor. Guide to the new cellular and gene-based technologies for basic and clinical investigators. Features a review of cell transplantation, discussions of principles and applications, methods for transfer to the heart in vivo, and protocols for vector production. Hardcover, e-book not yet available. |
|
Cardiac Electrophysiology: From Cell to Bedside by Douglas P. Zipes (Author), Jose Jalife (Author) This comprehensive reference provides the most authoritative and up-to-date information on cardiac electrophysiology - from cell to bedside. Coverage ranges from very basic reports on currents and channels, through theoretical and experimental bases of cardiac electrical activity and arrhythmias, to clinical understanding of mechanisms of arrhythmias and therapy to treat them. | |
 |
Stem Cell and Gene-Based Therapy: Frontiers in Regenerative Medicine by Alexander Battler (Editor), Jonathan Leor (Editor) The inability of the human body to be able significantly to self repair injured organs and tissues results in a considerable medical and social problem. During the last few years there has been incredible progress, and the achievements in experimental strategies for tissue regeneration, particularly in cell transplantation and stem cell research, have led to potential treatment options for many otherwise fatal conditions. These innovations hold promise for treating or preventing end-stage organ failure; cell therapy and tissue engineering of viable grafts with the potential to grow and remodel could provide prospective new solutions to the serious problems of organ donor shortage. Regenerative medicine – stem cell and gene-based therapy – offers a new approach for restoring... |
|
Bone marrow cells may help with variety of cardiac treatments: the use of bone marrow stem cells to repair damaged tissue helps the heart grow new blood ... An article from: Heart Advisor by Unavailable (Author) This digital document is an article from Heart Advisor, published by Belvoir Media Group, LLC on September 1, 2009. The length of the article is 687 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Bone marrow cells may help with variety of cardiac treatments: the use of bone marrow stem cells to repair damaged tissue helps the heart grow new blood vessels.(BREAKTHROUGHS) Author: Unavailable Publication: Heart Advisor (Magazine/Journal) Date: September 1, 2009 Publisher: Belvoir Media Group, LLC Volume: 12 Issue: 9 Page: 3(1) Distributed by Gale, a part of Cengage... | |
 |
Reviews of Physiology, Biochemistry and Pharmacology, Vol. 157 by S.G. Amara (Author), S.G. Amara;E. Bamberg;T. Gudermann;S.C. Hebert;R. Jahn;W.J. Lederer;R. Lill;A. Miyajima;S. Offermanns (Editor) Topics include embryonic and adult stem-cell derived cardiomyocytes; phylogenesis of constitutively formed nitric oxide in non-mammals; dimensions of systems biology; and structures, mechanism, regulation, and evolution of Class III nucleotidyl clyclases. For researchers. |
|
Advanced heart failure patients significantly improved after being injected with fetal stem cells.: An article from: Transplant News by Transplant Communications, Inc. (Publisher) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on June 10, 2005. The length of the article is 436 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Advanced heart failure patients significantly improved after being injected with fetal stem cells. Publication: Transplant News (Newsletter) Date: June 10, 2005 Publisher: Transplant Communications, Inc. Volume: 15 Issue: 11 Distributed by Thomson... | |
 |
An Introduction to Cardiac Electrophysiology by Antonio Zaza (Author), Michael Rosen (Author) Knowledge of the basic mechanisms of cardiac excitation is a prerequisite to the understanding of cardiac arrythmias and their response to therapy. The goal of this book is to provide readers unacquainted with the matter with the information necessary to develop pathophysiologically oriented clinical reasoning in this area. Besides covering normal aspects of cardiac cellular and tissue electrophysiology, An Introduction to Cardiac Electrophysiology illustrates recently acquired information on electronic abnormalities associated with cardiac disease and on molecular mechanisms of anti-arrhythmic drug action. The language used is suitable to address nonspecialists, and the reference to physics has been limited to very basic principles. Enclosed with the book is an interactive computer... |
| © 2009 BrightSurf.com |